Search Result "anti-PD-1/PD-L1."
Anti-VEGF/VEGFR2 Monoclonal Antibodies and their Combinations with PD-1/PD-L1 Inhibitors in Clinic
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 3-18
Author(s): Feng Gao,Chun Yang
Management of Immunotherapy Adverse Events in Oncological Patients: Anti-CTLA-4, Anti-PD-1/PD-L1
Journal: Reviews on Recent Clinical Trials
Volume: 15 Issue: 4 Year: 2020 Page: 339-346
Author(s): Mattia Brigida,Alessia Perricelli,Fausto Sposato,Maria Giovanna Spadafora,Angelo Pomillo,Milito Sisto
The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 5 Year: 2021 Page: 893-909
Author(s): Lifang Zhang,Yu Zhao,Quanmei Tu,Xiangyang Xue,Xueqiong Zhu,Kong-Nan Zhao
Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 2 Year: 2016 Page: 141-151
Author(s): Xiao-Na Fang,Li-Wu Fu
PD-L1 Signal Transduction Mechanisms in Cancer Cells
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 17 Issue: 2 Year: 2017 Page: 72-86
Author(s): Miren Zuazo-Ibarra,Maria Gato-Canas,Hugo Arasanz-Esteban,Gonzalo Fernandez-Hinojal,Maria Ibanez-Vea,Luisa Chocarro,Ruth Vera-Garcia,David Escors,Grazyna Kochan
Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 9 Year: 2017 Page: 839-845
Author(s): Djordje Atanackovic,Tim Luetkens,Sabari Radhakrishnan,Nicolaus Kroger
Beyond PD-1/PD-L1 Axis Blockade: New Combination Strategies in Metastatic Melanoma Treatment
Journal: Current Cancer Therapy Reviews
Volume: 15 Issue: 2 Year: 2019 Page: 110-119
Author(s): Emilio Francesco Giunta,Giuseppe Argenziano,Gabriella Brancaccio,Erika Martinelli,Fortunato Ciardiello,Teresa Troiani
The Clinical Safety and Efficacy of Targeted PD-L1 Therapy with Durvalumabin Solid Tumors
Journal: Current Drug Targets
Volume: 24 Issue: 7 Year: 2023 Page: 584-598
Author(s):
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 11 Year: 2018 Page: 1327-1339
Author(s): Gilda Varricchi,Giancarlo Marone,Valentina Mercurio,Maria Rosaria Galdiero,Domenico Bonaduce,Carlo G. Tocchetti
Melanoma: Prognostic Factors and Factors Predictive of Response to Therapy
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 17 Year: 2020 Page: 2792-2813
Author(s): Martina Strudel,Lucia Festino,Vito Vanella,Massimiliano Beretta,Francesco M. Marincola,Paolo A. Ascierto